Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

PharmaCyte Biotech (PMCB) Interest Coverage Ratio (2016 - 2022)

PharmaCyte Biotech (PMCB) has disclosed Interest Coverage Ratio for 11 consecutive years, with 544.95 as the latest value for Q1 2022.

  • On a quarterly basis, Interest Coverage Ratio rose 117.93% to 544.95 in Q1 2022 year-over-year; TTM through Oct 2022 was 4050.32, a 457.21% increase, with the full-year FY2022 number at 8628.71, down 625.45% from a year prior.
  • Interest Coverage Ratio was 544.95 for Q1 2022 at PharmaCyte Biotech, up from 622.97 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 544.95 in Q1 2022 to a low of 3039.55 in Q1 2021.
  • A 3-year average of 1454.29 and a median of 1528.96 in 2020 define the central range for Interest Coverage Ratio.
  • Peak YoY movement for Interest Coverage Ratio: rose 3.57% in 2021, then soared 117.93% in 2022.
  • PharmaCyte Biotech's Interest Coverage Ratio stood at 1402.53 in 2020, then skyrocketed by 55.58% to 622.97 in 2021, then soared by 187.48% to 544.95 in 2022.
  • Per Business Quant, the three most recent readings for PMCB's Interest Coverage Ratio are 544.95 (Q1 2022), 622.97 (Q4 2021), and 2191.33 (Q3 2021).